Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Umbilical Cord Blood Stem Cell Market is Expected to Reach $56.4 Billion, Globally, by 2020

This report provides market intelligence with respect to therapies, applications and storage services in cord blood stem cell market. Detailed analysis of top factors influencing the growth of UCB stem cell market so that companies can take developmental decision. Value chain analysis, Porters five forces, top investment pockets are analysed and presented in detail in the report. Intelligence of important regulatory and reimbursement issues is provided according to geographies so that companies can take strategic decisions

  • Login to see the comments

Umbilical Cord Blood Stem Cell Market is Expected to Reach $56.4 Billion, Globally, by 2020

  1. 1. Opportunity Analysis and Industry Forecast, 2016-2023 Stem Cell Umbilical Cord Blood (UCB) Market Trends, Cost Structure Analysis, Growth Opportunities Global Opportunity Analysis and Industry Forecast, 2012-2020
  2. 2. “Cord blood stem cell application is increasing a faster rate than other stem cell techniques because of its efficient and cost effective treatment process. Cord blood is assisting the healthcare industry to discover novel therapies for chronic diseases. UCB stem cell market is evidenced significant growth due to increasing public awareness and government support.” Stem Cell Umbilical Cord Blood (UCB) Market
  3. 3. Allied Market Research today announced the most comprehensive and strategically analyzed report titled World Stem Cell Umbilical Cord Blood (UCB) Market (Storage Services, Therapeutics, Applications and Geography) - Size, Share, Global Trends, Analysis, Opportunities, Growth, Intelligence and Forecast, 2012 - 2020" Access Full Summary at : https://www.alliedmarketresearch.com/stem-cell-umbilical- cord-blood-ucb-market The study observed that the global umbilical cord blood stem cell market is forecasted to reach market value over $11.5 billion in 2014 from $ 6.5billion in 2012. Developments and approvals for novel cord blood stem cells therapies is expected to drive the market growth. The market is expected to reach revenue of $56.4 billion by 2020, growing at CAGR of 33.4% during 2013 to 2020.The storage service market was valued at $7.4billion in 2013. Stem Cell Umbilical Cord Blood (UCB) Market Overview
  4. 4. Athersys, California Stem Cell Inc., and Cytori Therapeutics Inc. are engaged in the development of novel stem cell therapies from cord blood. Ethical issues regarding cord blood sample application is creating biasness among donor, which is majorly influencing the stem cell umbilical cord blood (UCB) market. Intense competition among stem cell umbilical cord blood (UCB) market players has been witnessed with the companies trying to create brand awareness. This is therefore, compelling the market players to formulate market based strategies. Cord blood stem cell is the only type of stem cell that is stored in controlled condition due to its lower volume higher cell count feature. Storage service segment is expected grow at 33.4% CAGR from 2013-2020 in the global stem cell umbilical cord blood (UCB) market. Stem Cell Umbilical Cord Blood (UCB) Market
  5. 5. According to lead analyst Debbie Shields, the geographic analysis shows that the North American market for cord blood stem cell would account for approx. 44% of total revenue generated by the cord blood market in 2013. However, much expected growth is to occur in Asia-Pacific regions during the forecast period, because of growing demand for chronic disease treatments and widely increasing awareness levels. This report study offers updated review about major market players present in this market such as researcher based pharmaceutical companies and therapeutics services companies. Company profiles in this report include - Advanced Cell Technology Inc., California Stem Cell Inc., Cytori Therapeutics Inc., Mesoblast Limited, Opexa Therapeutics Inc.(USA), Athersys Inc., Geron Corporation, and Neostem Inc. Stem Cell Umbilical Cord Blood (UCB) Market, Snapshot
  6. 6. • This report provides market intelligence with respect to therapies, applications and storage services in cord blood stem cell market. • Detailed analysis of top factors influencing the growth of UCB stem cell market so that companies can take developmental decision. • Value chain analysis, Porters five forces, top investment pockets are analysed and presented in detail in the report. • Intelligence of important regulatory and reimbursement issues is provided according to geographies so that companies can take strategic decisions. • SWOT analysis and strategic developments included in the report for Key players: Advanced Cell Technology, Inc. (USA), Athersys, California Stem Cell Inc., Cytori Therapeutics Inc., Mesoblast, Opexa Therapeutics Geron Corporation, Neostem Inc. Key Benefits of Stem Cell Umbilical Cord Blood (UCB) Market
  7. 7. Stem Cell Umbilical Cord Blood (UCB) Market North America Europe Asia-Pacific LAMEA
  8. 8. Stem Cell Umbilical Cord Blood (UCB) Market Thank You! For More Details Visit us at https://www.alliedmarketresearch.com/request- sample/114 Follow Us On

×